N@N

MRVL, BPHX, TSPT, SMA, PMI, EBS Expected To Be Down Before Next Earnings Releases

August 3, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and June earnings reports. MARVELL TECHNOLOGY GROUP LTD (NASDAQ:MRVL), BLUEPHOENIX SOLUTIONS LTD (NASDAQ:BPHX), TRANSCEPT PHARMACEUTICALS IN (NASDAQ:TSPT), SYMMETRY MEDICAL INC (NYSE:SMA), PMI GROUP INC/THE (NYSE:PMI), EMERGENT BIOSOLUTIONS, INC. (NYSE:EBS) are all expected to be Down Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down Before earnings are released Thursday:

     Symbol     Company                             # of Reports            Quarter     Release Date
     MRVL       MARVELL TECHNOLOGY GROUP LTD        6 Quarter               Q2          08/18/2011
     BPHX       BLUEPHOENIX SOLUTIONS LTD           12 Quarter              Q2          08/16/2011
     TSPT       TRANSCEPT PHARMACEUTICALS IN        12 Quarter              Q2          08/09/2011
     SMA        SYMMETRY MEDICAL INC                6 Quarter               Q2          08/04/2011
     PMI        PMI GROUP INC/THE                   12 Quarter              Q2          08/04/2011
     EBS        EMERGENT BIOSOLUTIONS, INC.         6 Quarter               Q2          08/04/2011

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

MARVELL TECHNOLOGY GROUP LTD (NASDAQ:MRVL) - Marvell Technology Group Ltd. designs, develops, and markets analog, mixed-signal, and digital signal processing and embedded microprocessor integrated circuits. The company offers storage products, including storage system-on-a-chip, read channel, hard disk controller, tape drive controllers, solid-state drive controllers, and storage-system products for hard disk drives, tape drive electronics, optical disk drives, solid-state flash drives, and storage subsystems technology; and switching products comprising Prestera switch family, Link Street multi-port integrated switch family, and Link Street gateway products. It also provides communications controller and embedded processor products, such as Discovery Innovation, Discovery system controllers, Horizon WAN communication controllers, Kirkwood embedded processor, and Orion embedded processor; and enterprise transceiver and PC connectivity products consisting of Alaska and Alaska X 10 Gigabit Ethernet transceiver families, Fast Ethernet transceiver family, and Yukon Gigabit Ethernet PC connectivity products. In addition, the company offers cellular and applications processor products that include communications processors, applications processors, and ecosystem partners; wireless and personal area networking products, such as Libertas wireless LAN family and Avastar multi-function wireless networking family; printing ASIC products; and digital video processing products. It also provides power management and green technology products, including DSP switcher integrated regulators, analog switching regulators, and digital PFC controllers. Marvell serves business enterprise, consumer electronics, and emerging markets primarily in the United States, Canada, China, Germany, Hong Kong, India, Israel, Italy, Japan, Korea, Malaysia, the Netherlands, Singapore, Sweden, Switzerland, Taiwan, and the United Kingdom. The company was founded in 1995 and is based in Hamilton, Bermuda.

BLUEPHOENIX SOLUTIONS LTD (NASDAQ:BPHX) - BluePhoenix Solutions Ltd. (BluePhoenix), incorporated in 1987, develops and markets enterprise information technology (IT) modernization solutions that enable companies to automate the process of modernizing and upgrading their mainframe and distributed IT infrastructure. The Company's complete modernization solutions consist of a combination of automated technologies and services that minimize the risk through the whole life cycle of the process. BluePhoenix solutions, which include technology for Understanding, Migration, Remediation and Redevelopment, allow companies to fully leverage their current systems and applications, speed up and reduce the cost of the renewal process, and effectively update their systems in order to adapt to new business demands. The Company's modernization solutions are offered to customers in all business market sectors, particularly financial services, banking, insurance and automotive.

In 2005, BluePhoenix acquired I-Ter/Informatica & Territorio S.p.A. (I-Ter). I-Ter develops and markets software solutions for migration from DL1 to DB2, and from IMS/DC to CICS, porting of applications from mainframe and Unix Sun Solaris.

Enterprise IT Understanding Solutions

Enterprise IT Understanding solutions enable companies to make informed strategic decisions regarding the future of their IT systems by automatically capturing multiple levels of operational and development information into a consolidated metadata warehouse. The Company's tools facilitate global assessments and impact analyses of application assets, thus helping reduce costs, streamline working processes and increase efficiency.

The BluePhoenix IT Discovery solution provides fast and convenient access to application inventory, dependency and operational information. This tool performs the complete audit necessary to enable companies to define and analyze all application assets in order to make informed decisions about ongoing modernization activities.

The BluePhoenix LogicMiner mines COBOL and extracts business rules from the legacy code, thus providing IT departments with the ability to begin a modernization process based on techniques that preserve the functionality of legacy code. This tool retains past investments in software assets by producing reusable code objects or descriptive data that can later be used for improving the quality of the legacy code, rewriting the legacy application, or building a full modernization plan.

Enterprise IT Migration Solutions

The Company's integrated set of enterprise IT migration solutions enable companies to standardize and consolidate their IT systems by automatically converting and redeploying applications, databases, platforms, programming languages and data that are implemented on outdated computing platforms.

BluePhoenix DBMSMigrator is an automated migration tool that converts applications from non-relational databases such as IDMS, ADABAS, IMS and VSAM to relational databases such as DB2, Oracle and SQL Server. The tool performs automated conversions that provide companies with fully functional compliance for source and target applications and minimal application, functional and logical program flow changes.

BluePhoenix PlatformMigrator is an automated migration tool that converts a range of platforms, including VSE, MVS and Bull GCOS, and can be customized to fit the IT configuration and business rules of each customer site. The tool converts platforms to a pure, native installation so that programs are not required to run under emulation or through translation techniques.

BluePhoenix Rehosting reduces the ongoing costs of existing legacy CICS and batch applications and leverages the strength and investment of older COBOL applications while taking advantage of operating system environments such as Linux, Unix, Windows, J2EE and .NET.

BluePhoenix LanguageMigrator is an automated migration tool for converting COBOL and 4GLs (fourth generation languages), such as ADSO, Natural, Mantis and PowerBuilder to COBOL and Java/J2EE. This solution enables site-w

TRANSCEPT PHARMACEUTICALS IN (NASDAQ:TSPT) - Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of proprietary products that address therapeutic needs in neuroscience. Its principal product includes Intermezzo, a sublingual low dose formulation of zolpidem that is being developed as a sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. The company has collaboration agreement with Purdue Pharmaceutical Products L.P. to commercialize Intermezzo in the United States. Transcept Pharmaceuticals, Inc. is headquartered in Point Richmond, California.

SYMMETRY MEDICAL INC (NYSE:SMA) - Symmetry Medical Inc. designs, develops, and produces implants and related surgical instruments and cases to orthopedic device manufacturers worldwide. It offers orthopedic implants that are used in reconstructive surgeries to replace or repair hips, knees, and other joints, such as shoulders, ankles, and elbows; trauma implant systems, which are used primarily to reattach or stabilize damaged bone or tissue while the body heals; and spinal implant systems, including plates and screws used by orthopedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and injuries in various regions of the spine. The company also provides surgical instruments, such as knee cutting blocks, osteotome revision systems, reamers, and retractors used in hip, knee, and shoulder reconstruction procedures, as well as in spinal, trauma, and other implant procedures. In addition, it produces a range of plastic, metal, and hybrid orthopedic cases to store, transport, and arrange surgical instruments and related implant systems, and other medical devices for orthopedic device manufacturers; endoscopy cases for endoscope sterilization; dental cases used in dental implant and general dental procedures; sterilization containers for the sterilization of various surgical instruments; and other cases for arthroscopy, osteobiologic, cardiovascular, ophthalmology, and diagnostic imaging, as well as ear, nose, and throat procedures. Further, the company engages in the design, engineering, and manufacturing of aerospace products comprising net shaped aerofoils and non-rotating aircraft engine forgings produced for the aerospace customers; and offers aerospace machining capabilities. The company was founded in 1976 and is headquartered in Warsaw, Indiana.

PMI GROUP INC/THE (NYSE:PMI) - The PMI Group, Inc., through its subsidiaries, provides residential mortgage insurance products that offer loss protection to mortgage lenders and investors in the event of borrower default in the United States. The company offers mortgage insurance products to meet the capital and credit risk mitigation needs of its customers. Its products include primary mortgage insurance through primary flow channel that provide the insured with first-loss mortgage default protection on individual loans at specified coverage percentages; and mortgage insurance to credit unions through its 50% joint venture interest in CMG Mortgage Insurance Company. The PMI Groups customers primarily include mortgage lenders, depository institutions, commercial banks, and investors. The company was founded in 1972 and is headquartered in Walnut Creek, California.

EMERGENT BIOSOLUTIONS, INC. (NYSE:EBS) - Emergent BioSolutions Inc. develops, manufactures, and commercializes immunobiotics such as vaccines and immune globulins that assist the bodys immune system. The companys biodefense segment develops, manufactures, and commercializes drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients after they are exposed to anthrax and botulinum toxin. Emergents commercial segment develops products for use against infectious diseases. These include a single-dose typhoid vaccine in phase II clinical development; a hepatitis B vaccine in phase II clinical development, and a group B streptococcus vaccine for women of childbearing age for protection of the fetus and newborn babies, which is in phase I clinical trials. Emergent is also developing chlamydia and meningitis B vaccines. Emergent primarily works for the U.S. Defense and Health & Human Services departments. It has collaboration agreements with the British Health Protection Agency for the development of a human botulinum immune globulin candidate and with Sanofi Pasteur for the development of meningitis B vaccine candidate. The company, which was founded in 1998, is based in Rockville, Maryland.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641